MEGAN BOERS: Open Payments
NPI 1316619562 · NEWTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 41 payments from 12 companies in 2025. Trend: 2023 $671 · 2024 $854 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $179 |
| ABBVIE INC. | 13 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $76 |
| PFIZER INC. | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Amgen Inc. | 2 | $34 |
| BETA BIONICS, INC. | 1 | $28 |
| Cranial Technologies, Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: AIRSUPRA, Kerendia, NURTEC ODT, GEMTESA, VRAYLAR, UBRELVY, EVENITY, BREZTRI.
Industry payments across KS — which companies pay providers there.
